Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

NCT05797558

This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.